Literature DB >> 27759855

Choroidal Changes in Anisometropic and Strabismic Children With Unilateral Amblyopia.

Christiane Al-Haddad, Maamoun Abdul Fattah, Karine Ismail, Ziad Bashshur.   

Abstract

BACKGROUND AND
OBJECTIVE: To detect changes in the choroidal layer at the macular area in amblyopic eyes. PATIENTS AND METHODS: A cross-sectional study of 50 amblyopic patients (20 strabismic and 30 anisometropic) and 50 controls was done. Cross-sectional images using enhanced depth optical coherence tomography (OCT) were taken. Thicknesses were measured subfoveally and at 1,500 µm nasally, temporally, inferiorly, and superiorly. Submacular corresponding choroidal areas were also computed. Parameters were compared between amblyopic eyes, fellow eyes, and controls.
RESULTS: Significantly thicker choroid was detected in the subfoveal, temporal, and nasal locations (P = .007, .009, and .01, respectively) in amblyopic compared to fellow eyes; areas were also significantly greater temporally, nasally, and inferiorly. Significant differences in all choroidal measurements were found between amblyopic eyes and controls; these persisted only in the anisometropic subgroup.
CONCLUSION: Using enhanced depth OCT, the choroid of amblyopic eyes was observed to be thicker compared to normal fellow eyes and controls. [Ophthalmic Surg Lasers Imaging Retina. 2016;47:900-907.]. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Year:  2016        PMID: 27759855     DOI: 10.3928/23258160-20161004-02

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  2 in total

1.  Macular Thickness in Moderate to Severe Amblyopia.

Authors:  Zhale Rajavi; Hamideh Sabbaghi; Narges Behradfar; Mehdi Yaseri; Mohammad Aghazadeh Amiri; Mohammad Faghihi
Journal:  Korean J Ophthalmol       Date:  2018-08

2.  How does anisometropia affect the choroidal vascularity index?

Authors:  Selim Cevher; Mehmet Barış Üçer; Tayfun Şahin
Journal:  Indian J Ophthalmol       Date:  2022-06       Impact factor: 2.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.